IDYA.US.EQUI (IDYA.US.EQUI) News
Follow IDYA.US.EQUI (IDYA.US.EQUI) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
Ideaya Biosciences price target lowered to $63 from $65 at Truist
Truist analyst Gregory Renza lowered the firm's price target on Ideaya Biosciences to $63 from $65 and keeps a Buy rating on the shares as part of a broader research note updating the firm's models and previewing Q2 earn
EQUITY | Jul 07, 2026, 01:15 PM UTC
H
Ideaya Biosciences price target lowered to $48 from $53 at RBC Capital
RBC Capital lowered the firm's price target on Ideaya Biosciences to $48 from $53 and keeps an Outperform rating on the shares as part of a broader research note previewing Q2 earnings in Biotech. The biotech sector has
EQUITY | Jul 07, 2026, 11:31 AM UTC